Pregled bibliografske jedinice broj: 1269171
The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation
The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation // Biomolecules, 13(4) (2023), 605, 15 doi:10.3390/biom13040605 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1269171 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The N-Glycosylation of Total Plasma Proteins and IgG
in Atrial Fibrillation
Autori
Plavša, Branimir ; Szavits-Nossan, Janko ; Blivajs, Aleksandar ; Rapčan, Borna ; Radovani, Barbara ; Šesto, Igor ; Štambuk, Krešimir ; Mustapić, Vito ; Đerek, Lovorka ; Rudan, Diana ; Lauc, Gordan ; Gudelj, Ivan
Izvornik
Biomolecules (2218-273X) 13(4)
(2023);
605, 15
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
atrial fibrillation ; N-glycosylation ; immunoglobulin G ; biomarker ; total plasma proteins ; pulmonary vein isolation
Sažetak
Atrial fibrillation is a disease with a complex pathophysiology, whose occurrence and persistence are caused not only by aberrant electrical signaling in the heart, but by the development of a susceptible heart substrate. These changes, such as the accumulation of adipose tissue and interstitial fibrosis, are characterized by the presence of inflammation. N-glycans have shown great promise as biomarkers in different diseases, specifically those involving inflammatory changes. To assess the changes in the N-glycosylation of the plasma proteins and IgG in atrial fibrillation, we analyzed the N-glycosylation of 172 patients with atrial fibrillation, before and six months after a pulmonary vein isolation procedure, with 54 cardiovascularly healthy controls. An analysis was performed using ultra- high-performance liquid chromatography. We found one oligomannose N-glycan structure from the plasma N-glycome and six IgG N-glycans, mainly revolving around the presence of bisecting N- acetylglucosamine, that were significantly different between the case and control groups. In addition, four plasma N-glycans, mostly oligomannose structures and a derived trait that was related to them, were found to be different in the patients who experienced an atrial fibrillation recurrence during the six-month follow-up. IgG N-glycosylation was extensively associated with the CHA2DS2-VASc score, confirming its previously reported associations with the conditions that make up the score. This is the first study looking at the N-glycosylation patterns in atrial fibrillation and warrants further investigation into the prospect of glycans as biomarkers for atrial fibrillation.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
HRZZ-UIP-2019-04-5692 - Glikozilacija u kardiovaskularnim bolestima (GLYCARD) (Gudelj, Ivan, HRZZ - 2019-04) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Medicinski fakultet, Osijek,
GENOS d.o.o.,
Sveučilište u Rijeci - Odjel za biotehnologiju
Profili:
Diana Rudan
(autor)
Gordan Lauc
(autor)
Borna Rapčan
(autor)
Krešimir Štambuk
(autor)
Ivan Gudelj
(autor)
Lovorka Đerek
(autor)
Barbara Radovani
(autor)
Branimir Plavša
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE